Skip to main content
Caplight Logo









Eos SENOLYTIX, Inc.

Eos SENOLYTIX, Inc.

Private
Houston, TexasHealthcare & Life Scienceshttps://eossenolytix.com/

Last Round

Private Placement

Mar 26, 2026

Est. Valuation

$119M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eos SENOLYTIX, Inc. is a biotechnology company that develops gerotherapeutic peptide medicines targeting mitochondrial dysfunction and senescent cells to improve healthspan and treat age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gerotherapeuticsgeropeptideslongevity biotechsenolyticsmitochondrial therapyanti-aging drugssarcopenia treatmentdrug discovery platformmetabolic healthhealthspanbiotechnologyprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eos SENOLYTIX, Inc. Comparables

Compare Eos SENOLYTIX, Inc. with similar companies based on industry and business-model similarity.

Eos SENOLYTIX, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deciduous Therapeutics
84%
Cleara Biotech
81%
Rubedo Life Sciences
81%

Eos SENOLYTIX, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMar 26, 2026
Series AFeb 26, 2025

Key People

Founding team and executive leadership

Kevin Slawin

Chairman, Founder and CEO

Founding Team

Eos SENOLYTIX, Inc. Investors

Notable investors and investment history

Eos SENOLYTIX, Inc. investors
InvestorRounds
Rapha Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 107% MoM, reaching 1.5K.

  • Mar 1, 2026

    Monthly visitors increased 85% MoM.

Eos SENOLYTIX, Inc. Filings

Explore SEC and related filing metadata, where available.

Eos SENOLYTIX, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eos SENOLYTIX, Inc.'s valuation, stock price, and market status.

Is Eos SENOLYTIX, Inc. a public or private company?

Eos SENOLYTIX, Inc. is a private company.

What is the current stock price of Eos SENOLYTIX, Inc.?

Eos SENOLYTIX, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Eos SENOLYTIX, Inc. worth (valuation)?

Eos SENOLYTIX, Inc.'s valuation is estimated at $119.0M based on funding round data.

Can I buy Eos SENOLYTIX, Inc. stock?

Eos SENOLYTIX, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eos SENOLYTIX, Inc.'s last funding round?

Eos SENOLYTIX, Inc.'s most recent funding round was Private Placement on March 26, 2026.

Who are the main investors in Eos SENOLYTIX, Inc.?

Key investors in Eos SENOLYTIX, Inc. include Rapha Capital Management.

Will Eos SENOLYTIX, Inc. IPO soon?

No public IPO plans have been announced for Eos SENOLYTIX, Inc..

How can I track Eos SENOLYTIX, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eos SENOLYTIX, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range4
Year Founded2019
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?